Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males-Reference-Cited by-同舟云学术

Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males

Published:2023-11-29 Issue:12 Volume:37 Page:1099-1109
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Goettel Markus,Fuertig Rene,Mack Salome Rebecca,Just Stefan,Sharma Vikas,Wunder Andreas,den Boer Johan

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-023-01042-3.pdf

Reference49 articles.

1. Liu WZ, Zhang WH, Zheng ZH, Zou JX, Liu XX, Huang SH, et al. Identification of a prefrontal cortex-to-amygdala pathway for chronic stress-induced anxiety. Nat Commun. 2020;11(1):2221.

2. Lueken U, Straube B, Yang Y, Hahn T, Beesdo-Baum K, Wittchen HU, et al. Separating depressive comorbidity from panic disorder: a combined functional magnetic resonance imaging and machine learning approach. J Affect Disord. 2015;184:182–92.

3. Wu Z, Cao L, Peng D, Mellor D, Zhang C, Li H, et al. The clinical correlates of comorbid anxiety symptoms and syndromal anxiety in patients with major depressive disorder. Psychiatry Res. 2018;269:251–7.

4. Zwanzger P, Domschke K, Bradwejn J. Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin. Depress Anxiety. 2012;29(9):762–74.

5. Eser D, Schüle C, Baghai T, Floesser A, Krebs-Brown A, Enunwa M, et al. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacol. 2007;192:479–87.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical challenges for testing novel anti-panic drugs in humans;Pharmacology Biochemistry and Behavior;2024-09

2. Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers;Clinical Drug Investigation;2024-04-24

3. Targeting TRP channels for pain relief: A review of current evidence from bench to bedside;Current Opinion in Pharmacology;2024-04

4. Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease;Frontiers in Neuroendocrinology;2024-04